NextPlat Corp (NXPL)
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-09-09
$8.88-0.84%
Close 2026-09-09 · 1-day change
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-09-09
Warn: Management is running behind on a stated commitment.
NextPlat aims to make a profit by Q3 2026. They plan to cut costs in 2026. The company wants more revenue from higher margin healthcare services. Margins grew in Q1 2026 despite lower sales.
NextPlat is still losing money and has weak profit margins. The company missed earnings recently. Management changes and legal issues add risk. Revenue growth may not meet analyst expectations.
The market expects about 27% revenue growth. Our fair value is near $61. The stock trades well below analyst price consensus. We see risk in profit and cost control execution.
Breaks if: operating income remains negative through Q3 2026
Continue turnaround efforts to improve operating income, targeting positive operating income in the third quarter of 2026.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story as NXPL aims to achieve positive operating income and expand its higher-margin services. The current thesis is cautious, given the company's recent struggles and elevated risk profile.
The valuation suggests that the market views NXPL as relatively cheap compared to its peers, with a negative expectations gap indicating that investors may have low expectations for future performance. The current pricing reflects a justified valuation, but the company's loss-making status is a concern.
Management is focused on improving operating income, with recent results showing progress in reducing losses. However, the mixed performance in expanding higher-margin services and the elevated risk level suggest that the path to consistent profitability may be uncertain in the near term.
The long-term thesis hinges on management's ability to achieve positive operating income in Q3 2026 and successfully expand its pharmacy footprint through strategic acquisitions. Additionally, broader market conditions, such as potential interest rate cuts and performance from sector leaders, could significantly impact NXPL's trajectory.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports confidence in NXPL's performance. Record margins reinforce the goal to grow e-Commerce revenue and improve margins. There are no new threats impacting the thesis.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 3 of last 3 quarters. Operating loss improved significantly from $(1,103) thousand in 2026-Q1 to $(127) thousand in 2026-Q2, and net loss decreased from $(1,118) thousand to $(144) thousand over the same period. Management's trajectory is delivering with substantial progress toward positive operating income in Q3 2026.
“Management continues to expect that the addition of higher-margin contracted healthcare services revenue supported by the Company9s more efficient expense structure will contribute to sustainable po…”
“Management expects that the addition of higher margin contracted healthcare services revenue combined with reduced levels of operating expenses throughout 2026 will enable the Company to achieve posi…”
“The Company anticipates achieving positive operating income in Q3 2026.”
Breaks if: healthcare services revenue does not grow next year
Breaks if: operating expenses do not decline in 2026
Continue cost discipline and streamline operations to reduce total operating expenses and improve profitability.
Stated as a priority in 3 of last 3 quarters. Operating expenses declined approximately 8% in 2026-Q2 excluding one-time fees and decreased about 9% in 2026-Q1 versus 2025-Q4. Management is delivering ongoing cost discipline and streamlining efforts.
“Operating expenses declined approximately 8% excluding a one-time increase in professional fees.”
“Total operating expenses decreased approximately 9% sequentially versus Q4 2025 reflecting turnaround efforts.”
“Ongoing refocusing and streamlining efforts led to decreases in salaries, wages, and professional fees.”
Breaks if: revenue estimate falls below $48 million in 2026 or $72 million in 2027
Over the next 1 to 3 years, NXPL's future will depend on its operational improvements and external market factors. Not investment advice.